F Dx Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

F Dx Advisors, Inc.

$659 Million
Q1 2024

A detailed history of F Dx Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, F Dx Advisors, Inc. holds 2,621 shares of CRL stock, worth $523,308. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,621

Previous 3,639 27.97%

Holding current value

$523,308

Previous $860,000 17.44%

% of portfolio

0.11%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$203.52 - $273.43 $207,183 - $278,351	-1,018 Reduced 27.97%	2,621 $710,000
Q4 2023 Feb 12, 2024	SELL	$164.52 - $238.84 $74,363 - $107,955	-452 Reduced 11.05%	3,639 $860,000
Q3 2023 Nov 02, 2023	SELL	$194.44 - $217.61 $938,950 - $1.05 Million	-4,829 Reduced 54.14%	4,091 $801,000
Q2 2023 Jul 17, 2023	SELL	$183.71 - $210.25 $112,246 - $128,462	-611 Reduced 6.41%	8,920 $1.88 Million
Q4 2022 Feb 09, 2023	SELL	$197.11 - $250.07 $381,210 - $483,635	-1,934 Reduced 16.87%	9,531 $2.08 Million

Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $327,114 - $449,218	-1,793 Reduced 13.52%	11,465 $2.26 Million
Q2 2022 Aug 03, 2022	BUY	$204.13 - $302.4 $51,440 - $76,204	252 Added 1.94%	13,258 $2.84 Million
Q1 2022 May 03, 2022	BUY	$255.51 - $362.11 $90,706 - $128,549	355 Added 2.81%	13,006 $3.69 Million
Q4 2021 Feb 01, 2022	BUY	$351.38 - $448.68 $313,430 - $400,222	892 Added 7.59%	12,651 $4.77 Million
Q3 2021 Oct 08, 2021	BUY	$372.64 - $458.3 $354,008 - $435,385	950 Added 8.79%	11,759 $4.85 Million
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $325,646 - $411,416	1,107 Added 11.41%	10,809 $4 Million
Q1 2021 Apr 14, 2021	BUY	$249.67 - $299.48 $1.72 Million - $2.06 Million	6,890 Added 245.02%	9,702 $2.81 Million
Q1 2021 Apr 13, 2021	SELL	$249.67 - $299.48 $541,284 - $649,272	-2,168 Reduced 43.53%	2,812 $815,000
Q4 2020 Feb 08, 2021	BUY	$222.0 - $252.62 $229,548 - $261,209	1,034 Added 26.2%	4,980 $1.24 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $287,391 - $370,698	-1,637 Reduced 29.32%	3,946 $894,000
Q2 2020 Jul 22, 2020	BUY	$118.84 - $189.72 $306,607 - $489,477	2,580 Added 85.91%	5,583 $973,000
Q1 2020 May 22, 2020	SELL	$98.9 - $178.34 $1.08 Million - $1.95 Million	-10,941 Reduced 78.46%	3,003 $379,000
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $1.01 Million - $1.82 Million	10,178 Added 270.26%	13,944 $96,000
Q4 2019 Feb 12, 2020	SELL	$126.05 - $152.76 $2,521 - $3,055	-20 Reduced 0.53%	3,766 $575,000
Q3 2019 Nov 07, 2019	BUY	$125.07 - $143.67 $41,773 - $47,985	334 Added 9.68%	3,786 $501,000
Q2 2019 Jul 19, 2019	SELL	$123.4 - $148.55 $3,455 - $4,159	-28 Reduced 0.8%	3,452 $490,000
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $61,529 - $86,130	-587 Reduced 14.43%	3,480 $505,000
Q4 2018 Apr 29, 2019	SELL	$105.09 - $137.23 $10,929 - $14,271	-104 Reduced 2.49%	4,067 $460,000
Q4 2018 Feb 07, 2019	SELL	$105.09 - $137.23 $107,822 - $140,797	-1,026 Reduced 19.74%	4,171 $472,000
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $84,755 - $101,712	756 Added 17.02%	5,197 $699,000
Q2 2018 Aug 08, 2018	SELL	$102.37 - $117.25 $6,346 - $7,269	-62 Reduced 1.38%	4,441 $499,000
Q1 2018 May 02, 2018	SELL	$98.19 - $115.2 $103,590 - $121,536	-1,055 Reduced 18.98%	4,503 $481,000
Q4 2017 Feb 09, 2018	BUY	$100.43 - $118.09 $48,708 - $57,273	485 Added 9.56%	5,558 $608,000
Q3 2017 Nov 03, 2017	BUY	$96.72 - $109.26 $490,660 - $554,275	5,073	5,073 $548,000

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account